William Blair initiated coverage of Cullinan Oncology with an Outperform rating.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGEM:
- Cullinan Management’s Capital Dilemma: Balancing Equity, Debt, and Partnerships to Avoid Dilution and Restrictions
- Cullinan Oncology announces departure of CFO Jeff Trigilio
- Cullinan Oncology expects cash to provide runway into 2H26
- Cullinan Oncology reports Q4 EPS (54c), consensus (96c)
- Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results